BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33444184)

  • 1. Repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK: a cost-effectiveness analysis.
    Huntington S; Weston G; Seedat F; Marshall J; Bailey H; Tebruegge M; Ahmed I; Turner K; Adams E
    BMJ Open; 2020 Nov; 10(11):e038505. PubMed ID: 33444184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Screening for Syphilis in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
    Hersh AR; Megli CJ; Caughey AB
    Obstet Gynecol; 2018 Sep; 132(3):699-707. PubMed ID: 30095767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategic options for antenatal screening for syphilis in the United Kingdom: a cost effectiveness analysis.
    Connor N; Roberts J; Nicoll A
    J Med Screen; 2000; 7(1):7-13. PubMed ID: 10807140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis.
    Albright CM; Emerson JB; Werner EF; Hughes BL
    Obstet Gynecol; 2015 Sep; 126(3):479-485. PubMed ID: 26244531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of Point-of-Care Rapid Testing Versus Laboratory-Based Testing for Antenatal Screening of Syphilis in Brazil.
    Romero CP; Marinho DS; Castro R; de Aguiar Pereira CC; Silva E; Caetano R; Silva Elias FT; Chilcott J; Dixon S
    Value Health Reg Issues; 2020 Dec; 23():61-69. PubMed ID: 32841902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
    Bristow CC; Larson E; Anderson LJ; Klausner JD
    Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa.
    Rydzak CE; Goldie SJ
    Sex Transm Dis; 2008 Sep; 35(9):775-84. PubMed ID: 18607319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
    Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
    Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model.
    Kahn JG; Jiwani A; Gomez GB; Hawkes SJ; Chesson HW; Broutet N; Kamb ML; Newman LM
    PLoS One; 2014; 9(1):e87510. PubMed ID: 24489931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syphilis in pregnant women and their children in the United Kingdom: results from national clinician reporting surveys 1994-7.
    Hurtig AK; Nicoll A; Carne C; Lissauer T; Connor N; Webster JP; Ratcliffe L
    BMJ; 1998 Dec; 317(7173):1617-9. PubMed ID: 9848899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal screening for hepatitis B infection and syphilis in the UK.
    Newell ML; Thorne C; Pembrey L; Nicoll A; Goldberg D; Peckham C
    Br J Obstet Gynaecol; 1999 Jan; 106(1):66-71. PubMed ID: 10426262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania.
    Watson-Jones D; Oliff M; Terris-Prestholt F; Changalucha J; Gumodoka B; Mayaud P; Semakafu AM; Kumaranayake L; Gavyole A; Mabey D; Hayes R
    Trop Med Int Health; 2005 Sep; 10(9):934-43. PubMed ID: 16135202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.
    Schackman BR; Neukermans CP; Fontain SN; Nolte C; Joseph P; Pape JW; Fitzgerald DW
    PLoS Med; 2007 May; 4(5):e183. PubMed ID: 17535105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal syphilis screening using point-of-care testing in low- and middle-income countries in Asia and Latin America: a cost-effectiveness analysis.
    Kuznik A; Muhumuza C; Komakech H; Marques EM; Lamorde M
    PLoS One; 2015; 10(5):e0127379. PubMed ID: 26010366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of universal antenatal screening for HIV in New Zealand.
    Bramley D; Graves N; Walker D
    AIDS; 2003 Mar; 17(5):741-8. PubMed ID: 12646798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings.
    Zakiyah N; Tuytten R; Baker PN; Kenny LC; Postma MJ; van Asselt ADI;
    PLoS One; 2022; 17(4):e0267313. PubMed ID: 35446907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syphilis screening in pregnancy in the United Kingdom, 2010-2011: a national surveillance study.
    Townsend CL; Francis K; Peckham CS; Tookey PA
    BJOG; 2017 Jan; 124(1):79-86. PubMed ID: 27219027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Surveillance Data to Respond to an Outbreak of Congenital Syphilis in Arizona Through Third-Trimester Screening Policies, 2017-2018.
    Sykes KJ; Scranton RA; Villarroel L; Anderson BV; Salek S; Stall J
    Public Health Rep; 2021; 136(1):61-69. PubMed ID: 33211993
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.